Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.

Mr. Yuanyuan  Li

Joint Company Secretary

Mr. Biao  Li

Vice President

Mr. Shiwen  Lv

Chairman, Chief Executive Officer & Chief Technology Officer

Mr. Fei  Pan

Chief Financial Officer, Vice President & Executive Director

Mr. Bo  Hu

IT Director & Supervisor

Mr. Wai Chiu  Wong FCS

Nome da empresa	Capitalização de mercado
NeueHealth, Inc.	0M
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.	0M
YSB Inc.	0M
Clínica Las Condes S.A.	0M
Delcath Systems, Inc.	0M
OneMedNet Corporation	0M
GPT Healthcare Limited	0M
Accuray Incorporated	0M
Yatharth Hospital & Trauma Care Services Limited	0M
Gaush Meditech Ltd	0M

Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd. Lista de concorrentes

Principais concorrentes